GLAXOSMITHKLINE (GSK) has again advised that due to high global demand for Bexsero (meningococcal B) vaccine, the product will be unavailable for supply in Australia until early 2017.
Bexsero is not currently available on the National Immunisation Program, but increasing demand means supply to Australia is currently constrained.
The company advises those affected to visit www.tga.gov.au for ongoing updates to supply, and regrets any inconvenience to patients seeking the vaccine as well as pharmacists and doctors.
GSK medical information will also take calls on 1800 033 109.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Nov 16
